ChemicalBook--->CAS DataBase List--->2359-60-6

2359-60-6

2359-60-6 Structure

2359-60-6 Structure
IdentificationMore
[Name]

4-Piperidinoaniline
[CAS]

2359-60-6
[Synonyms]

1-(4-AMINOPHENYL)PIPERIDINE
4-(1-PIPERIDINO)ANILINE
4-PIPERIDIN-1-YLANILINE
4-PIPERIDIN-1-YL-PHENYLAMINE
4-PIPERIDINOANILINE
AKOS B033030
AKOS BB-8563
ASISCHEM V33555
BUTTPARK 97\12-13
LABOTEST-BB LT00455366
N-(4-AMINOPHENYL)PIPERIDINE
TIMTEC-BB SBB010087
4-Piperidinoaniline,98%
1-(p-Aminophenyl)piperidine
4-(1-PIPERIDINO)ANILINE [1-(4-AMINOPHENYL)PIPERIDINE]
4-(1-PIPERIDINO)ANILINE, 97+%
4-(1-Piperidinyl)aniline
4-piperidin-1-ylaniline hydrochloride
4-(1-Piperidinyl)aniline, 97+%
[Molecular Formula]

C11H16N2
[MDL Number]

MFCD00051688
[Molecular Weight]

176.26
[MOL File]

2359-60-6.mol
Chemical PropertiesBack Directory
[Melting point ]

26-29 °C(lit.)
[Boiling point ]

140-142°C 1mm
[density ]

1.074±0.06 g/cm3(Predicted)
[refractive index ]

n20/D 1.5937(lit.)
[Fp ]

>230 °F
[storage temp. ]

2-8°C
[form ]

low melting solid
[pka]

7.79±0.10(Predicted)
[color ]

Brown to black
[BRN ]

139525
[CAS DataBase Reference]

2359-60-6(CAS DataBase Reference)
Safety DataBack Directory
[Hazard Codes ]

Xi,Xn
[Risk Statements ]

R36/37/38:Irritating to eyes, respiratory system and skin .
R36/37:Irritating to eyes and respiratory system .
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .
[Safety Statements ]

S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S22:Do not breathe dust .
[RIDADR ]

2811
[WGK Germany ]

3
[Hazard Note ]

Harmful
[HazardClass ]

6.1
[PackingGroup ]

III
[HS Code ]

29333990
Material Safety Data Sheet(MSDS)Back Directory
[msds information]

4-Piperidinoaniline(2359-60-6).msds
Hazard InformationBack Directory
[Uses]

Reactant for synthesis of:
  • Amino acid arylamides
  • Selective interleukin-2 inducible T-cell inhibitors
  • Antimalarial drugs
  • Aglycoristocetin derivatives for anti-influenza virus activity
  • IRAK-4 inhibitors
  • 9-Aminoacridines with antiprion activity
[Synthesis]

1-(4-Nitrophenyl)piperidine

6574-15-8

4-Piperidinoaniline

2359-60-6

The general procedure for the synthesis of 1-(4-nitrophenyl)piperidine was as follows: first, 4-fluoronitrobenzene (323 mg, 2.3 mmol) was dissolved in DMSO (5 mL), followed by the addition of potassium carbonate (475 mg, 3.5 mmol) and piperidine (460 μL, 4.6 mmol). The reaction mixture was stirred at 90 °C for 9 hours. After completion of the reaction, water was added to the reaction solution and extracted twice with ethyl acetate. The organic layers were combined and washed twice with saturated aqueous NaCl followed by drying with anhydrous Na2CO3. The solvent was evaporated under reduced pressure to give 1-(4-nitrophenyl)piperidine (Y197, yield: 472 mg, 100%). Next, Y197 (472 mg) was dissolved in ethyl acetate (20 mL), Pd/C (186 mg) was added, and the reaction was stirred for 3 h at room temperature under hydrogen atmosphere. Upon completion of the reaction, the reaction mixture was filtered through diatomaceous earth and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: chloroform:methanol = 40:1) to afford 1-(4-aminophenyl)piperidine (Y222, yield: 394 mg, quantitative). Finally, Y491 (80 mg, 0.18 mmol) was dissolved in dichloromethane (2 mL), Y222 (100 mg, 0.58 mmol) was added and stirred at room temperature for 5 hours. After the reaction was completed, the solvent was concentrated under reduced pressure and the residue was purified by silica gel column chromatography (eluent: chloroform:methanol = 35:1) to afford the target product 1-(p-aminophenyl)piperidine (yield: 68 mg, 64%). The structure of the product was confirmed by 1H NMR, 13C NMR and HRMS.1H NMR (500 MHz, CDCl3) δ 8.40 (s, 1H), 8.0 (d, 1H, J = 8.0 Hz), 7.70 (d, 1H, J = 8.5 Hz), 7.52 (dd, 1H, J = 8.0, 7.5 Hz), 6.92 (dd, 2H, J = 9.0, 3.5 Hz), 6.92 (dd, 2H, J = 9.0, 3.5 Hz). = 9.0, 3.5 Hz), 6.77 (dd, 2H, J = 9.0, 6.5 Hz), 5.33 (t, 1H, J = 6.0 Hz), 4.07 (bs, 2H), 3.11-3.09 (m, 4H), 2.79-2.64 (m, 4H), 1.69-1.53 (m, 10H), 1.43 (s, 9H), 1.09-1.01 (m, 9H) 1.09-1.01 (m, 2H).13C NMR (125 MHz, CDCl3) δ 154.9, 141.6, 140.8, 131.4, 130.9, 129.8, 125.8, 125.7, 79.7, 77.4, 48.7, 36.6, 29.6, 28.6, 25.7, 24.2.HRMS ( FAB-) m/z: [M-H]- calculated value C28H39N4O6S2, 591.2311; measured value, 591.2324.

[References]

[1] Patent: US2013/45977, 2013, A1. Location in patent: Paragraph 0211; 0212; 0213; 0214
[2] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 15, p. 3057 - 3061
[3] Patent: US2009/239848, 2009, A1. Location in patent: Page/Page column 25
[4] Journal of Medicinal Chemistry, 2013, vol. 56, # 12, p. 4849 - 4859
[5] Patent: CN105503775, 2016, A. Location in patent: Paragraph 0042
Spectrum DetailBack Directory
[Spectrum Detail]

4-Piperidinoaniline(2359-60-6)1HNMR
4-Piperidinoaniline(2359-60-6)IR
Tags:2359-60-6 Related Product Information
52-86-8 95-68-1 95-64-7 62-53-3 28983-56-4 548-73-2 915-30-0 110-89-4 39643-31-7 6574-15-8 2359-60-6

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.